Back
Alternatives to blood transfusion.
Journal article

Alternatives to blood transfusion.

  • Spahn DR Institute of Anaesthesiology, University and University Hospital Zurich, Zurich, Switzerland. donat.spahn@usz.ch
  • Goodnough LT
  • 2013-05-28
Published in:
  • Lancet (London, England). - 2013
Anemia
Antifibrinolytic Agents
Blood Coagulation Disorders
Blood Loss, Surgical
Blood Transfusion
Chronic Disease
Costs and Cost Analysis
Erythropoiesis
Hematinics
Hemorrhage
Hemostasis, Surgical
Hemostatics
Humans
Patient Care Planning
Point-of-Care Systems
Preoperative Care
Professional Practice
Thoracic Surgical Procedures
Transfusion Reaction
Wounds and Injuries
English The use of alternatives to allogeneic blood continues to rest on the principles that blood transfusions have inherent risks, associated costs, and affect the blood inventory available for health-care delivery. Increasing evidence exists of a fall in the use of blood because of associated costs and adverse outcomes, and suggests that the challenge for the use of alternatives to blood components will similarly be driven by costs and patient outcomes. Additionally, the risk-benefit profiles of alternatives to blood transfusion such as autologous blood procurement, erythropoiesis-stimulating agents, and haemostatic agents are under investigation. Nevertheless, the inherent risks of blood, along with the continued rise in blood costs are likely to favour the continued development and use of alternatives to blood transfusion. We summarise the current roles of alternatives to blood in the management of medical and surgical anaemias.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/66194
Statistics
Document views: 9 File downloads: